propidium has been researched along with threonine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Copik, AJ; Johnson, BH; Kumar, R; Miller, AL; Thompson, EB; Wang, Y; Webb, MS | 1 |
1 other study(ies) available for propidium and threonine
| Article | Year |
|---|---|
p38 Mitogen-activated protein kinase (MAPK) is a key mediator in glucocorticoid-induced apoptosis of lymphoid cells: correlation between p38 MAPK activation and site-specific phosphorylation of the human glucocorticoid receptor at serine 211.
Topics: Alanine; Animals; Apoptosis; Cell Line; Cell Line, Tumor; Cell Survival; Dexamethasone; DNA; Enzyme Activation; Flow Cytometry; Glucocorticoids; Humans; Immunohistochemistry; Kinetics; Lymphocytes; MAP Kinase Kinase 3; MAP Kinase Signaling System; Mice; Models, Biological; Mutation; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Propidium; Proto-Oncogene Proteins c-myc; Receptors, Glucocorticoid; RNA, Messenger; Serine; Signal Transduction; Threonine; Time Factors; Transcriptional Activation; Transfection | 2005 |